Cannaflos Genetics

Cannaflos is a German biotechnology and pharmaceutical company focused on the development of standardized medical cannabis products. Through its Cannaflos Genetics division, the company utilizes advanced breeding techniques and genomic analysis to create stabilized cannabis chemotypes tailored for specific therapeutic indications. Cannaflos operates under strict EU-GMP standards to ensure the quality and consistency of its cannabinoid-based medicines. The company serves the European market by providing high-quality starting materials for cultivation and finished pharmaceutical products for patient care. Their mission is to bridge the gap between botanical complexity and pharmaceutical precision in the medical cannabis industry.